AbbVie Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ABBV New York 2834 https://www.abbvie.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AbbVie Inc

See what the IHS Markit Score report has to say about AbbVie Inc. - Dec 15th, 2018 6:01 am
[$$] Companies Ramp Up Stock Buybacks as Market Swoon Continues - Dec 14th, 2018 5:13 pm
AbbVie May Yield More Than It Appears - Dec 14th, 2018 10:27 am
AbbVie Announces $5 Billion Increase to Stock Repurchase Program - Dec 13th, 2018 11:00 am
5 Pharma Stocks That Could Cure Ailing Portfolios in 2019 - Dec 12th, 2018 8:51 am
Mavyret Is a Leading Drug in AbbVie’s HCV Franchise - Dec 12th, 2018 5:30 am
AbbVie- High Yield at a Low Valuation - Dec 12th, 2018 3:00 am
Gilead Sciences (GILD) Appoints Daniel O'Day as New CEO - Dec 11th, 2018 1:55 pm
7 Stocks Wall Street Is Souring on Right Now - Dec 11th, 2018 12:20 pm
Venclexta: A Solid Growth Driver for AbbVie in Future Years - Dec 11th, 2018 8:30 am
Bristol-Myers to Study Opdivo in Combo With Vedanta's VE800 - Dec 11th, 2018 7:51 am
Imbruvica: A Major Oncology Asset for AbbVie in 2018 - Dec 11th, 2018 7:00 am
Humira: AbbVie’s Major Revenue Driver in 2018 - Dec 11th, 2018 5:30 am
How Worried Should You Be About AbbVie's $5.8 Billion Boondoggle? - Dec 11th, 2018 4:01 am
AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know - Dec 10th, 2018 3:45 pm
Don’t Punish Gilead Stock for Doing Its Job - Dec 10th, 2018 8:33 am
Humira’s Biosimilar Competition in International Markets - Dec 10th, 2018 8:31 am
Amgen (AMGN) Continues to Reward Shareholders, Ups Dividend - Dec 10th, 2018 7:13 am
Considering AbbVie’s 2018 Expense Projections - Dec 10th, 2018 7:01 am
Timely Ten- Top Values from IQ Trends - Dec 5th, 2018 3:00 am